Compass Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CMPX and other ETFs, options, and stocks.About CMPX
Compass Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of proprietary antibody therapeutics. Its platform includes common light chain-focused antibody discovery, human display for antibody tuning, stitchmabs, and highly modular and manufacturable bispecific candidates.
CEOThomas J. Schuetz
CEOThomas J. Schuetz
Employees35
Employees35
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2014
Founded2014
Employees35
Employees35
CMPX Key Statistics
Market cap1.16B
Market cap1.16B
Price-Earnings ratio-14.25
Price-Earnings ratio-14.25
Dividend yield—
Dividend yield—
Average volume2.33M
Average volume2.33M
High today$6.69
High today$6.69
Low today$6.25
Low today$6.25
Open price$6.35
Open price$6.35
Volume2.01M
Volume2.01M
52 Week high$6.88
52 Week high$6.88
52 Week low$1.33
52 Week low$1.33
Stock Snapshot
The current Compass Therapeutics(CMPX) stock price is $6.52, with a market capitalization of 1.16B. The stock trades at a price-to-earnings (P/E) ratio of -14.25.
On 2026-02-08, Compass Therapeutics(CMPX) stock moved within a range of $6.25 to $6.69. With shares now at $6.52, the stock is trading +4.3% above its intraday low and -2.5% below the session's peak.
Trading volume for Compass Therapeutics(CMPX) stock has reached 2.01M, versus its average volume of 2.33M.
Over the past 52 weeks, Compass Therapeutics(CMPX) stock has traded between a high of $6.88 and a low of $1.33.
Over the past 52 weeks, Compass Therapeutics(CMPX) stock has traded between a high of $6.88 and a low of $1.33.
Analyst ratings
100%
of 15 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own CMPX. This list is generated using Robinhood data, and it’s not a recommendation.